IBDEI0Z9 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,15916,0)
;;=L57.0^^61^765^13
;;^UTILITY(U,$J,358.3,15916,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15916,1,3,0)
;;=3^Actinic Keratosis
;;^UTILITY(U,$J,358.3,15916,1,4,0)
;;=4^L57.0
;;^UTILITY(U,$J,358.3,15916,2)
;;=^66900
;;^UTILITY(U,$J,358.3,15917,0)
;;=L60.0^^61^765^164
;;^UTILITY(U,$J,358.3,15917,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15917,1,3,0)
;;=3^Ingrowing Nail
;;^UTILITY(U,$J,358.3,15917,1,4,0)
;;=4^L60.0
;;^UTILITY(U,$J,358.3,15917,2)
;;=^5009234
;;^UTILITY(U,$J,358.3,15918,0)
;;=L60.1^^61^765^272
;;^UTILITY(U,$J,358.3,15918,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15918,1,3,0)
;;=3^Onycholysis
;;^UTILITY(U,$J,358.3,15918,1,4,0)
;;=4^L60.1
;;^UTILITY(U,$J,358.3,15918,2)
;;=^186837
;;^UTILITY(U,$J,358.3,15919,0)
;;=L60.2^^61^765^271
;;^UTILITY(U,$J,358.3,15919,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15919,1,3,0)
;;=3^Onychogryphosis
;;^UTILITY(U,$J,358.3,15919,1,4,0)
;;=4^L60.2
;;^UTILITY(U,$J,358.3,15919,2)
;;=^5009235
;;^UTILITY(U,$J,358.3,15920,0)
;;=L60.3^^61^765^176
;;^UTILITY(U,$J,358.3,15920,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15920,1,3,0)
;;=3^Nail Dystrophy
;;^UTILITY(U,$J,358.3,15920,1,4,0)
;;=4^L60.3
;;^UTILITY(U,$J,358.3,15920,2)
;;=^5009236
;;^UTILITY(U,$J,358.3,15921,0)
;;=L60.4^^61^765^89
;;^UTILITY(U,$J,358.3,15921,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15921,1,3,0)
;;=3^Beau's Lines
;;^UTILITY(U,$J,358.3,15921,1,4,0)
;;=4^L60.4
;;^UTILITY(U,$J,358.3,15921,2)
;;=^5009237
;;^UTILITY(U,$J,358.3,15922,0)
;;=L60.5^^61^765^330
;;^UTILITY(U,$J,358.3,15922,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15922,1,3,0)
;;=3^Yellow Nail Syndrome
;;^UTILITY(U,$J,358.3,15922,1,4,0)
;;=4^L60.5
;;^UTILITY(U,$J,358.3,15922,2)
;;=^5009238
;;^UTILITY(U,$J,358.3,15923,0)
;;=L60.8^^61^765^174
;;^UTILITY(U,$J,358.3,15923,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15923,1,3,0)
;;=3^Nail Disorders NEC
;;^UTILITY(U,$J,358.3,15923,1,4,0)
;;=4^L60.8
;;^UTILITY(U,$J,358.3,15923,2)
;;=^5009239
;;^UTILITY(U,$J,358.3,15924,0)
;;=L62.^^61^765^175
;;^UTILITY(U,$J,358.3,15924,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15924,1,3,0)
;;=3^Nail Disorders in Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,15924,1,4,0)
;;=4^L62.
;;^UTILITY(U,$J,358.3,15924,2)
;;=^5009241
;;^UTILITY(U,$J,358.3,15925,0)
;;=L64.9^^61^765^34
;;^UTILITY(U,$J,358.3,15925,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15925,1,3,0)
;;=3^Androgenic Alopecia,Unspec
;;^UTILITY(U,$J,358.3,15925,1,4,0)
;;=4^L64.9
;;^UTILITY(U,$J,358.3,15925,2)
;;=^5009249
;;^UTILITY(U,$J,358.3,15926,0)
;;=L65.9^^61^765^269
;;^UTILITY(U,$J,358.3,15926,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15926,1,3,0)
;;=3^Nonscarring Hair Loss,Unspec
;;^UTILITY(U,$J,358.3,15926,1,4,0)
;;=4^L65.9
;;^UTILITY(U,$J,358.3,15926,2)
;;=^5009252
;;^UTILITY(U,$J,358.3,15927,0)
;;=L70.0^^61^765^7
;;^UTILITY(U,$J,358.3,15927,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15927,1,3,0)
;;=3^Acne Vulgaris
;;^UTILITY(U,$J,358.3,15927,1,4,0)
;;=4^L70.0
;;^UTILITY(U,$J,358.3,15927,2)
;;=^5009268
;;^UTILITY(U,$J,358.3,15928,0)
;;=L70.1^^61^765^2
;;^UTILITY(U,$J,358.3,15928,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,15928,1,3,0)
;;=3^Acne Conglobata
;;^UTILITY(U,$J,358.3,15928,1,4,0)
;;=4^L70.1
;;^UTILITY(U,$J,358.3,15928,2)
;;=^5009269
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0Z9 3770 printed Apr 09, 2024@21:59:02 Page 2
IBDEI0Z9 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,15916,0)
+2 ;;=L57.0^^61^765^13
+3 ;;^UTILITY(U,$J,358.3,15916,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,15916,1,3,0)
+6 ;;=3^Actinic Keratosis
+7 ;;^UTILITY(U,$J,358.3,15916,1,4,0)
+8 ;;=4^L57.0
+9 ;;^UTILITY(U,$J,358.3,15916,2)
+10 ;;=^66900
+11 ;;^UTILITY(U,$J,358.3,15917,0)
+12 ;;=L60.0^^61^765^164
+13 ;;^UTILITY(U,$J,358.3,15917,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,15917,1,3,0)
+16 ;;=3^Ingrowing Nail
+17 ;;^UTILITY(U,$J,358.3,15917,1,4,0)
+18 ;;=4^L60.0
+19 ;;^UTILITY(U,$J,358.3,15917,2)
+20 ;;=^5009234
+21 ;;^UTILITY(U,$J,358.3,15918,0)
+22 ;;=L60.1^^61^765^272
+23 ;;^UTILITY(U,$J,358.3,15918,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,15918,1,3,0)
+26 ;;=3^Onycholysis
+27 ;;^UTILITY(U,$J,358.3,15918,1,4,0)
+28 ;;=4^L60.1
+29 ;;^UTILITY(U,$J,358.3,15918,2)
+30 ;;=^186837
+31 ;;^UTILITY(U,$J,358.3,15919,0)
+32 ;;=L60.2^^61^765^271
+33 ;;^UTILITY(U,$J,358.3,15919,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,15919,1,3,0)
+36 ;;=3^Onychogryphosis
+37 ;;^UTILITY(U,$J,358.3,15919,1,4,0)
+38 ;;=4^L60.2
+39 ;;^UTILITY(U,$J,358.3,15919,2)
+40 ;;=^5009235
+41 ;;^UTILITY(U,$J,358.3,15920,0)
+42 ;;=L60.3^^61^765^176
+43 ;;^UTILITY(U,$J,358.3,15920,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,15920,1,3,0)
+46 ;;=3^Nail Dystrophy
+47 ;;^UTILITY(U,$J,358.3,15920,1,4,0)
+48 ;;=4^L60.3
+49 ;;^UTILITY(U,$J,358.3,15920,2)
+50 ;;=^5009236
+51 ;;^UTILITY(U,$J,358.3,15921,0)
+52 ;;=L60.4^^61^765^89
+53 ;;^UTILITY(U,$J,358.3,15921,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,15921,1,3,0)
+56 ;;=3^Beau's Lines
+57 ;;^UTILITY(U,$J,358.3,15921,1,4,0)
+58 ;;=4^L60.4
+59 ;;^UTILITY(U,$J,358.3,15921,2)
+60 ;;=^5009237
+61 ;;^UTILITY(U,$J,358.3,15922,0)
+62 ;;=L60.5^^61^765^330
+63 ;;^UTILITY(U,$J,358.3,15922,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,15922,1,3,0)
+66 ;;=3^Yellow Nail Syndrome
+67 ;;^UTILITY(U,$J,358.3,15922,1,4,0)
+68 ;;=4^L60.5
+69 ;;^UTILITY(U,$J,358.3,15922,2)
+70 ;;=^5009238
+71 ;;^UTILITY(U,$J,358.3,15923,0)
+72 ;;=L60.8^^61^765^174
+73 ;;^UTILITY(U,$J,358.3,15923,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,15923,1,3,0)
+76 ;;=3^Nail Disorders NEC
+77 ;;^UTILITY(U,$J,358.3,15923,1,4,0)
+78 ;;=4^L60.8
+79 ;;^UTILITY(U,$J,358.3,15923,2)
+80 ;;=^5009239
+81 ;;^UTILITY(U,$J,358.3,15924,0)
+82 ;;=L62.^^61^765^175
+83 ;;^UTILITY(U,$J,358.3,15924,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,15924,1,3,0)
+86 ;;=3^Nail Disorders in Diseases Classified Elsewhere
+87 ;;^UTILITY(U,$J,358.3,15924,1,4,0)
+88 ;;=4^L62.
+89 ;;^UTILITY(U,$J,358.3,15924,2)
+90 ;;=^5009241
+91 ;;^UTILITY(U,$J,358.3,15925,0)
+92 ;;=L64.9^^61^765^34
+93 ;;^UTILITY(U,$J,358.3,15925,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,15925,1,3,0)
+96 ;;=3^Androgenic Alopecia,Unspec
+97 ;;^UTILITY(U,$J,358.3,15925,1,4,0)
+98 ;;=4^L64.9
+99 ;;^UTILITY(U,$J,358.3,15925,2)
+100 ;;=^5009249
+101 ;;^UTILITY(U,$J,358.3,15926,0)
+102 ;;=L65.9^^61^765^269
+103 ;;^UTILITY(U,$J,358.3,15926,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,15926,1,3,0)
+106 ;;=3^Nonscarring Hair Loss,Unspec
+107 ;;^UTILITY(U,$J,358.3,15926,1,4,0)
+108 ;;=4^L65.9
+109 ;;^UTILITY(U,$J,358.3,15926,2)
+110 ;;=^5009252
+111 ;;^UTILITY(U,$J,358.3,15927,0)
+112 ;;=L70.0^^61^765^7
+113 ;;^UTILITY(U,$J,358.3,15927,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,15927,1,3,0)
+116 ;;=3^Acne Vulgaris
+117 ;;^UTILITY(U,$J,358.3,15927,1,4,0)
+118 ;;=4^L70.0
+119 ;;^UTILITY(U,$J,358.3,15927,2)
+120 ;;=^5009268
+121 ;;^UTILITY(U,$J,358.3,15928,0)
+122 ;;=L70.1^^61^765^2
+123 ;;^UTILITY(U,$J,358.3,15928,1,0)
+124 ;;=^358.31IA^4^2
+125 ;;^UTILITY(U,$J,358.3,15928,1,3,0)
+126 ;;=3^Acne Conglobata
+127 ;;^UTILITY(U,$J,358.3,15928,1,4,0)
+128 ;;=4^L70.1
+129 ;;^UTILITY(U,$J,358.3,15928,2)
+130 ;;=^5009269
